🇺🇸 FDA
Pipeline program

Trangorex 200 mg comprimidos

PERIVERSION

Approved small_molecule active

Quick answer

Trangorex 200 mg comprimidos for Atrial fibrillation is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Atrial fibrillation
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials